Skip to content
Application 020262
- Type
- NDA
- Sponsor
- HQ SPCLT PHARMA
Application Products#
Product, Drug, Ingredient table| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|
| 001 | TAXOL | PACLITAXEL | INJECTABLE;INJECTION | 6MG/ML | Yes | No |
NDC Listings For This Application#
NDC, Name, Nonproprietary name table| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|
| 44567-504 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-504 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-504 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-505 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-505 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-505 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-506 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-506 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |
| 44567-506 | Paclitaxel | Paclitaxel | WG Critical Care, LLC | NDA | Current |